Neopterin levels in nonreplicative HBV carriers

Hepatology Research

Volumn 24, Issue 1, 2002, Pages 18-22

  Kiliç, Dilek ^a,c   Boyunaǧa, Hakan ^a   Kaygusuz, Sedat ^a   Akgül, E Özgür ^b   Al Rashed, Munzer ^b   Kenar, Levent ^b   Erbil, Kemal ^b   Kutluay, Türker ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

HBV carriage; Hepatitis B virus; Neopterin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; NEOPTERIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; MALE; PRIORITY JOURNAL; REFERENCE VALUE; STATISTICAL ANALYSIS; VIRUS CARRIER; VIRUS LOAD; VIRUS REPLICATION;

EID: 0036740515     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00012-8     Document Type: Article

References (27)

1. Chisari FV, Ferari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
2. Mendy M, Fortuin M, Hall AS, Jack AD, Whittle HC. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage. Br J Biochem Sci 1999;56:34-8.
3. Hilleman MR. Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. Vaccine 2001;19:1837-48.
4. Huber CH, Batchelor R, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. Immune response-associated production of neopterin. J Exp Med 1984;160:310-6.
5. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Immunol 1993;101:1-6.
6. Schermach H, Mayerbach P, Schönitzer D, Fuchs D, Wachter H, Reibnegger G. Increased prevalence of IgM antibodies to Epstein-Barr virus and Parvovirus B19 in blood donations with above-normal neopterin concentration. Clin Chem 1994;40:2104.
7. Oda K, Arai T, Nagase M. Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction. Am J Kidney Dis 1999;34:611-7,
8. Barak M, Gruener N. Neopterin augmentation of tumor necrosis factor production. Immunol Lett 1991;30:101-6.
9. Müller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta 1991;201:1-16.
10. Vincent JL. Procalcitonin: the marker of sepsis? Crit Care Med 2000;28:1227-8.
11. Widner B, Bitterlich GB, Wede I, Wirleitner B, Wachter H, Fuchs D. Neopterin: indicator of oxidative stress and part of the cytotoxic armature of activated macrophages in humans. Pteridin 1998;9:91-102.
12. Horak E, Gassner I, Sölder B, Wachter H, Fuchs D. Neopterin levels and pulmonary tuberculosis in infants. Lung 1998;176:337-44.
13. Prasad AS, Fitzgerald JT, Bao B, Beak FWS, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Ann Intern Med 2000;133:245-52.
14. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity. Immunol Today 1988;9:150-5.
15. Fuchs D, Shearer MG, Boswell RN, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin Exp Immunol 1990;80:44-8.
16. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation, transplantation, inflammatory, infectious and malignant diseases. Clin Rev Clin Lab Sci 1992;29:307-41.
17. Schennach H, Schönitzer D, Fuchs D. Association between chronic hepatitis C virus infection and increased neopterin concentrations in blood donations. Clin Chem 1998;44:2225-6.
18. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev 2000; 174:98 -111.
19. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001;120:1009-22.
20. Robinson WS. In: Mandell GL, Bennet JE, Dolin R, editors. Hepatitis B and hepatitis D virus. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone, 2000:1652-84.
21. Carreno V, Zeuzem S, Hopf U, Marcellin P, Cooksley WGE, Fevery J, Diago M, Reddy R, Peters M, Rittweger K, Rakhit A, Pardo M. A phase I/II study of recombinant human interleukin-12 with chronic hepatitis B. J Hepatol 2000;32:317-24.
22. Zeuzem S, Hopf U, Carreno V, Diago M, Shiffman M, Grüne S, Dudley FJ, Rakhit A, Rittweger K, Yap HS, Koff SR, Thomas HC. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C. Hepatology 1999;29:1280-7,
23. The Hepatitis Intervention Therapy Group, Glue P, Fang J, Panis RR, Rafenel C, Sabo R, Gupta SK, Salli M, Jacobs S. Pegylated interferon-a2b: pharmacokinetics, pharmacodinamics, safety and preliminary efficacy data. Clin Pharm Ther 2000;68:556-67.
24. Pas SD, Fries E, De Man RA, Osterhaus ADM, Niesters HG. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000;38:2897-901.
25. Niesters HGM, Krajden M, Cork L, de Medina M, Hill M, Fries E, Ostrehaus ADME. A multicenter study evaluation of the Digene Hybrid Capture II Signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol 2000;38:2150-5.
26. Chan HLY, Leung NWY, Lau TCM, Wong ML, Sung JJY. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J Clin Microbiol 2000;38:3205-8.
27. Pawlotsky JM, Bastie A, Hezode C, Lonjon I, Darthuy F, Remire J, Dhumeaux D. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods 2000;85:11-21.